Dissertation - Life Sciences bibliographies - in Harvard style

In-text: (A. Armstrong, 2012)

Your Bibliography: A. Armstrong, R., 2012. On the ‘classification’ of neurodegenerative disorders: discrete entities, overlap or continuum?. fn, 3, pp.201-218.

In-text: (Agorogiannis, Agorogiannis, Papadimitriou and Hadjigeorgiou, 2004)

Your Bibliography: Agorogiannis, E., Agorogiannis, G., Papadimitriou, A. and Hadjigeorgiou, G., 2004. Protein misfolding in neurodegenerative diseases. Neuropathology and Applied Neurobiology, 30(3), pp.215-224.

In-text: (Ahn et al., 2010)

Your Bibliography: Ahn, H., Zamolodchikov, D., Cortes-Canteli, M., Norris, E., Glickman, J. and Strickland, S., 2010. Alzheimer's disease peptide  -amyloid interacts with fibrinogen and induces its oligomerization. Proceedings of the National Academy of Sciences, 107(50), pp.21812-21817.

In-text: (Amani and Naeem, 2013)

Your Bibliography: Amani, S. and Naeem, A., 2013. Understanding protein folding from globular to amyloid state. Process Biochemistry, 48(11), pp.1651-1664.

In-text: (Arispe, Rojas and Pollard, 1993)

Your Bibliography: Arispe, N., Rojas, E. and Pollard, H., 1993. Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. Proceedings of the National Academy of Sciences, 90(2), pp.567-571.

In-text: (Armstrong, Cairns, Ironside and Lantos, 2005)

Your Bibliography: Armstrong, R., Cairns, N., Ironside, J. and Lantos, P., 2005. Size frequency distribution of prion protein (PrP) aggregates in variant Creutzfeldt-Jakob disease (vCJD). Journal of Neural Transmission, 112(11), pp.1565-1573.

In-text: (Armstrong, Lantos and Cairns, 2005)

Your Bibliography: Armstrong, R., Lantos, P. and Cairns, N., 2005. Overlap between neurodegenerative disorders. Neuropathology, 25(2), pp.111-124.

In-text: (Ballard et al., 2011)

Your Bibliography: Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D. and Jones, E., 2011. Alzheimer's disease. The Lancet, 377(9770), pp.1019-1031.

In-text: (Ballatore, Lee and Trojanowski, 2007)

Your Bibliography: Ballatore, C., Lee, V. and Trojanowski, J., 2007. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nature Reviews Neuroscience, 8(9), pp.663-672.

In-text: (Ballatore et al., 2011)

Your Bibliography: Ballatore, C., R. Brunden, K., Q. Trojanowski, J., M.-Y. Lee, V., B. Smith, A. and M. Huryn, D., 2011. Modulation of Protein-Protein Interactions as a Therapeutic Strategy for the Treatment of Neurodegenerative Tauopathies. CTMC, 11(3), pp.317-330.

In-text: (Bednarska, Schymkowitz, Rousseau and Van Eldere, 2013)

Your Bibliography: Bednarska, N., Schymkowitz, J., Rousseau, F. and Van Eldere, J., 2013. Protein aggregation in bacteria: the thin boundary between functionality and toxicity. Microbiology, 159(Pt_9), pp.1795-1806.

In-text: (Beekes, Thomzig, Schulz-Schaeffer and Burger, 2014)

Your Bibliography: Beekes, M., Thomzig, A., Schulz-Schaeffer, W. and Burger, R., 2014. Is there a risk of prion-like disease transmission by Alzheimer- or Parkinson-associated protein particles?. Acta Neuropathologica, 128(4), pp.463-476.

In-text: (Broncel, Krause, Schwarzer and Hackenberger, 2012)

Your Bibliography: Broncel, M., Krause, E., Schwarzer, D. and Hackenberger, C., 2012. The Alzheimer’s Disease Related Tau Protein as a New Target for Chemical Protein Engineering. Chemistry - A European Journal, 18(9), pp.2488-2492.

In-text: (Bulic et al., 2009)

Your Bibliography: Bulic, B., Pickhardt, M., Schmidt, B., Mandelkow, E., Waldmann, H. and Mandelkow, E., 2009. Development of Tau Aggregation Inhibitors for Alzheimer's Disease. Angew. Chem. Int. Ed., 48(10), pp.1740-1752.

In-text: (Calzolai et al., 2005)

Your Bibliography: Calzolai, L., Lysek, D., Perez, D., Guntert, P. and Wuthrich, K., 2005. Prion protein NMR structures of chickens, turtles, and frogs. Proceedings of the National Academy of Sciences, 102(3), pp.651-655.

In-text: (Clavaguera et al., 2013)

Your Bibliography: Clavaguera, F., Lavenir, I., Falcon, B., Frank, S., Goedert, M. and Tolnay, M., 2013. “Prion-Like” Templated Misfolding in Tauopathies. Brain Pathology, 23(3), pp.342-349.

In-text: (Cohen and Kelly, 2003)

Your Bibliography: Cohen, F. and Kelly, J., 2003. Therapeutic approaches to protein-misfolding diseases. Nature, 426(6968), pp.905-909.

In-text: (DaRocha-Souto et al., 2011)

Your Bibliography: DaRocha-Souto, B., Scotton, T., Coma, M., Serrano-Pozo, A., Hashimoto, T., Serenó, L., Rodríguez, M., Sánchez, B., Hyman, B. and Gómez-Isla, T., 2011. Brain Oligomeric β-Amyloid but Not Total Amyloid Plaque Burden Correlates With Neuronal Loss and Astrocyte Inflammatory Response in Amyloid Precursor Protein/Tau Transgenic Mice. Journal of Neuropathology and Experimental Neurology, 70(5), pp.360-376.

In-text: (Demuro, Smith and Parker, 2011)

Your Bibliography: Demuro, A., Smith, M. and Parker, I., 2011. Single-channel Ca2+ imaging implicates A 1-42 amyloid pores in Alzheimer's disease pathology. The Journal of Cell Biology, 195(3), pp.515-524.

In-text: (Denny, Gavrin and Saiah, 2013)

Your Bibliography: Denny, R., Gavrin, L. and Saiah, E., 2013. Recent developments in targeting protein misfolding diseases. Bioorganic & Medicinal Chemistry Letters, 23(7), pp.1935-1944.

In-text: (Diamond, 2013)

Your Bibliography: Diamond, M., 2013. Introduction. Neurotherapeutics, 10(3), pp.369-370.

In-text: (Forloni, Sclip, Borsello and Balducci, 2013)

Your Bibliography: Forloni, G., Sclip, A., Borsello, T. and Balducci, C., 2013. The neurodegeneration in Alzheimer disease and the prion protein. Prion, 7(1), pp.60-65.

In-text: (FORLONI et al., 2002)

Your Bibliography: FORLONI, G., TERRENI, L., BERTANI, I., FOGLIARINO, S., INVERNIZZI, R., ASSINI, A., RIBIZZI, G., NEGRO, A., CALABRESE, E. and VOLONTE, M., 2002. Protein misfolding in Alzheimer’s and Parkinson’s disease: genetics and molecular mechanisms. Neurobiology of Aging, 23(5), pp.957-976.

In-text: (Gavrin, Denny and Saiah, 2012)

Your Bibliography: Gavrin, L., Denny, R. and Saiah, E., 2012. Small Molecules That Target Protein Misfolding. Journal of Medicinal Chemistry, 55(24), pp.10823-10843.

In-text: (Goedert, Falcon, Clavaguera and Tolnay, 2014)

Your Bibliography: Goedert, M., Falcon, B., Clavaguera, F. and Tolnay, M., 2014. Prion-like Mechanisms in the Pathogenesis of Tauopathies and Synucleinopathies. Current Neurology and Neuroscience Reports, 14(11).

In-text: (Graner, Cumming and Bigner, 2007)

Your Bibliography: Graner, M., Cumming, R. and Bigner, D., 2007. The Heat Shock Response and Chaperones/Heat Shock Proteins in Brain Tumors: Surface Expression, Release, and Possible Immune Consequences. Journal of Neuroscience, 27(42), pp.11214-11227.

In-text: (Hirakura, Azimov, Azimova and Kagan, 2000)

Your Bibliography: Hirakura, Y., Azimov, R., Azimova, R. and Kagan, B., 2000. Polyglutamine-induced ion channels: a possible mechanism for the neurotoxicity of huntington and other CAG repeat diseases. Journal of Neuroscience Research, 60(4), pp.490-494.

In-text: (Hoffmann, Neupane and Woodside, 2013)

Your Bibliography: Hoffmann, A., Neupane, K. and Woodside, M., 2013. Single-molecule assays for investigating protein misfolding and aggregation. Phys. Chem. Chem. Phys., 15(21), p.7934.

In-text: (Hope, 2000)

Your Bibliography: Hope, J., 2000. Prions and neurodegenerative diseases. Current Opinion in Genetics & Development, 10(5), pp.568-574.

In-text: (Huang et al., 2013)

Your Bibliography: Huang, P., Lian, F., Wen, Y., Guo, C. and Lin, D., 2013. Prion protein oligomer and its neurotoxicity. Acta Biochimica et Biophysica Sinica, 45(6), pp.442-451.

In-text: (Hung et al., 2010)

Your Bibliography: Hung, C., Chen, Y., Hsieh, W., Chiou, S. and Kao, C., 2010. Ageing and neurodegenerative diseases. Ageing Research Reviews, 9, pp.S36-S46.

In-text: (Imbimbo, 2002)

Your Bibliography: Imbimbo, B., 2002. Toxicity of ?-amyloid vaccination in patients with Alzheimer's disease. Annals of Neurology, 51(6), pp.794-794.

In-text: (Karplus, 2011)

Your Bibliography: Karplus, M., 2011. Behind the folding funnel diagram. Nature Chemical Biology, 7(7), pp.401-404.

In-text: (Kim et al., 2013)

Your Bibliography: Kim, Y., Hipp, M., Bracher, A., Hayer-Hartl, M. and Ulrich Hartl, F., 2013. Molecular Chaperone Functions in Protein Folding and Proteostasis. Annu. Rev. Biochem., 82(1), pp.323-355.

In-text: (Kmiecik and Kolinski, 2011)

Your Bibliography: Kmiecik, S. and Kolinski, A., 2011. Simulation of Chaperonin Effect on Protein Folding: A Shift from Nucleation–Condensation to Framework Mechanism. J. Am. Chem. Soc., 133(26), pp.10283-10289.

In-text: (Kretzschmar and Tatzelt, 2013)

Your Bibliography: Kretzschmar, H. and Tatzelt, J., 2013. Prion Disease: A Tale of Folds and Strains. Brain Pathology, 23(3), pp.321-332.

In-text: (Lei et al., 2010)

Your Bibliography: Lei, P., Ayton, S., Finkelstein, D., Adlard, P., Masters, C. and Bush, A., 2010. Tau protein: Relevance to Parkinson's disease. The International Journal of Biochemistry & Cell Biology, 42(11), pp.1775-1778.

In-text: (M. Niedowicz, T. Nelson and Paul Murphy, 2011)

Your Bibliography: M. Niedowicz, D., T. Nelson, P. and Paul Murphy, M., 2011. Alzheimers Disease: Pathological Mechanisms and Recent Insights. CN, 9(4), pp.674-684.

In-text: (McGeer, 2008)

Your Bibliography: McGeer, P., 2008. Amyloid-β vaccination for Alzheimer's dementia. The Lancet, 372(9647), p.1381.

In-text: (Molloy and Chen, 2005)

Your Bibliography: Molloy, D. and Chen, B., 2005. Predicted consequences of site-directed mutagenesis and the impact of species variation on prion protein misfolding through the N-terminal domain. Journal of Molecular Modeling, 11(6), pp.468-473.

In-text: (Narayanan and Scarlata, 2001)

Your Bibliography: Narayanan, V. and Scarlata, S., 2001. Membrane Binding and Self-Association of α-Synucleins †. Biochemistry, 40(33), pp.9927-9934.

In-text: (Newberg et al., 2013)

Your Bibliography: Newberg, A., Serruya, M., Wintering, N., Moss, A., Reibel, D. and Monti, D., 2013. Meditation and neurodegenerative diseases. Ann. N.Y. Acad. Sci., 1307(1), pp.112-123.

In-text: (Pasinetti et al., 2010)

Your Bibliography: Pasinetti, G., Ksiezak-Reding, H., Santa-Maria, I., Wang, J. and Ho, L., 2010. Development of a grape seed polyphenolic extract with anti-oligomeric activity as a novel treatment in progressive supranuclear palsy and other tauopathies. Journal of Neurochemistry, 114(6), pp.1557-1568.

In-text: (Pasinetti et al., 2010)

Your Bibliography: Pasinetti, G., Ksiezak-Reding, H., Santa-Maria, I., Wang, J. and Ho, L., 2010. Development of a grape seed polyphenolic extract with anti-oligomeric activity as a novel treatment in progressive supranuclear palsy and other tauopathies. Journal of Neurochemistry, 114(6), pp.1557-1568.

In-text: (Pierce et al., 2010)

Your Bibliography: Pierce, A., Wei, R., Halade, D., Yoo, S., Ran, Q. and Richardson, A., 2010. A Novel mouse model of enhanced proteostasis: Full-length human heat shock factor 1 transgenic mice. Biochemical and Biophysical Research Communications, 402(1), pp.59-65.

In-text: (Raslan and Kee, 2013)

Your Bibliography: Raslan, A. and Kee, Y., 2013. Tackling neurodegenerative diseases: animal models of Alzheimer’s disease and Parkinson’s disease. Genes & Genomics, 35(4), pp.425-440.

In-text: (Reitz, 2012)

Your Bibliography: Reitz, C., 2012. Alzheimer's Disease and the Amyloid Cascade Hypothesis: A Critical Review. International Journal of Alzheimer's Disease, 2012, pp.1-11.

In-text: (Riess, Berg, Krüger and Schulz, 2003)

Your Bibliography: Riess, O., Berg, D., Krüger, R. and Schulz, J., 2003. Therapeutic strategies for Parkinson's disease based on data derived from genetic research. J Neurol, 250(S1), pp.i3-i10.

In-text: (Santa-Maria et al., 2012)

Your Bibliography: Santa-Maria, I., Varghese, M., Ksiezak-Reding, H., Dzhun, A., Wang, J. and Pasinetti, G., 2012. Paired Helical Filaments from Alzheimer Disease Brain Induce Intracellular Accumulation of Tau Protein in Aggresomes. Journal of Biological Chemistry, 287(24), pp.20522-20533.

In-text: (Singh, Kumar, Sabareesan and Udgaonkar, 2014)

Your Bibliography: Singh, J., Kumar, H., Sabareesan, A. and Udgaonkar, J., 2014. Rational Stabilization of Helix 2 of the Prion Protein Prevents Its Misfolding and Oligomerization. J. Am. Chem. Soc., 136(48), pp.16704-16707.

In-text: (Soto, 2003)

Your Bibliography: Soto, C., 2003. Unfolding the role of protein misfolding in neurodegenerative diseases. Nature Reviews Neuroscience, 4(1), pp.49-60.

In-text: (Steffan, 2004)

Your Bibliography: Steffan, J., 2004. SUMO Modification of Huntingtin and Huntington's Disease Pathology. Science, 304(5667), pp.100-104.

In-text: (Stohr et al., 2008)

Your Bibliography: Stohr, J., Weinmann, N., Wille, H., Kaimann, T., Nagel-Steger, L., Birkmann, E., Panza, G., Prusiner, S., Eigen, M. and Riesner, D., 2008. Mechanisms of prion protein assembly into amyloid. Proceedings of the National Academy of Sciences, 105(7), pp.2409-2414.

In-text: (Sugiyama and Tanaka, 2014)

Your Bibliography: Sugiyama, S. and Tanaka, M., 2014. Self-propagating amyloid as a critical regulator for diverse cellular functions. Journal of Biochemistry, 155(6), pp.345-351.

In-text: (Thompson, 2008)

Your Bibliography: Thompson, L., 2008. Neurodegeneration: A question of balance. Nature, 452(7188), pp.707-708.

In-text: (Uttara, Singh, Zamboni and Mahajan, 2009)

Your Bibliography: Uttara, B., Singh, A., Zamboni, P. and Mahajan, R., 2009. Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options. CN, 7(1), pp.65-74.

In-text: (Uversky, 2014)

Your Bibliography: Uversky, V., 2014. The triple power of D³: Protein intrinsic disorder in degenerative diseases. Front Biosci, 19(2), p.181.

In-text: (Vila-Viçosa, Campos, Baptista and Machuqueiro, 2012)

Your Bibliography: Vila-Viçosa, D., Campos, S., Baptista, A. and Machuqueiro, M., 2012. Reversibility of Prion Misfolding: Insights from Constant-pH Molecular Dynamics Simulations. J. Phys. Chem. B, 116(30), pp.8812-8821.

In-text: (Williams and Paulson, 2008)

Your Bibliography: Williams, A. and Paulson, H., 2008. Polyglutamine neurodegeneration: protein misfolding revisited. Trends in Neurosciences, 31(10), pp.521-528.